Digital diet app for people on GLP-1 therapy
Part of Hormones & metabolism clinical trials.
This study tests a smartphone app that gives dietary advice to people who are overweight or obese and also take a GLP-1 medication (like semaglutide) for weight or diabetes. The app will help you follow a healthy eating plan while using the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You are overweight or obese and have a related health condition (like diabetes, high blood pressure, or high cholesterol).
- You are already taking or are about to start a GLP-1 medication (such as semaglutide) prescribed by your doctor.
- You own a smartphone and are willing to use a health app for the study.
- Your chronic medications (like for blood pressure or cholesterol) have been stable for the past 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartphone app with artificial intelligence to help Chinese adults who are overweight or obese manage their metabolic health. Participants will receive personalized guidance and monitoring to improve their weight and overall health.
This study tests two ways of logging food in a mobile app to help with weight loss. It compares how easy each way is to use and whether one helps people lose more weight.
This study teaches adults on GLP-1 medication (like Ozempic or Wegovy) how to eat better and lose weight using a smartphone app. Researchers want to see if personalized nutrition advice helps you get better results from your medication.
This study is testing whether a 4-month digital lifestyle program (with a Fitbit) can help people who recently started taking a GLP-1 medication make healthier habits and lose more weight. You would use an app or website to get support and track your progress.
This trial tests a smartphone-based lifestyle program to help people with newly diagnosed type 2 diabetes lose weight and improve blood sugar control. You'll get a digital program with coaching and support, instead of usual care alone.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.